ASMB ASSEMBLY BIOSCIENCES INC revenue, earnings and financials

For the quarter ended June 30, 2026, ASSEMBLY BIOSCIENCES INC reported revenue of $13.4M (up 38.9% from a year earlier), net income of −$3.86M and diluted EPS of −$0.20; over the last four quarters revenue was $74.8M and net income −$42.0K; for the fiscal year ended December 2025 revenue was $72.3M, up 153.5% on the year before.

ASMB annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $72.3M, gross profit n/a, operating income −$12.1M, net income −$6.12M (margin -8.5%), EPS −$0.55
• Fiscal year ended Dec 2024: revenue $28.5M, gross profit n/a, operating income −$45.4M, net income −$40.2M (margin -140.9%), EPS −$6.69
• Fiscal year ended Dec 2023: revenue $7.16M, gross profit n/a, operating income −$64.6M, net income −$61.2M (margin -854.8%), EPS −$13.38
• Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$94.1M, net income −$93.1M (margin n/a), EPS −$23.08
• Fiscal year ended Dec 2021: revenue $6.25M, gross profit n/a, operating income −$133M, net income −$130M (margin -2076.4%), EPS −$3.00

ASMB quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $13.4M (up 38.9% year over year), net income −$3.86M, EPS −$0.20
• Quarter ended Mar 31, 2026: revenue $8.21M (down 12.8% year over year), net income −$9.08M, EPS −$0.54
• Quarter ended Dec 31, 2025 (from the annual report): revenue $42.5M (up 477.3% year over year), net income $22.1M, EPS $2.67
• Quarter ended Sep 30, 2025: revenue $10.8M (up 57.6% year over year), net income −$9.20M, EPS −$0.72
• Quarter ended Jun 30, 2025: revenue $9.63M (up 12.8% year over year), net income −$10.2M, EPS −$1.33
• Quarter ended Mar 31, 2025: revenue $9.42M (up 62.8% year over year), net income −$8.82M, EPS −$1.17
• Quarter ended Dec 31, 2024 (from the annual report): revenue $7.36M (up 2.7% year over year), net income −$10.3M, EPS −$1.54
• Quarter ended Sep 30, 2024: revenue $6.85M, net income −$9.61M, EPS −$1.51
• Quarter ended Jun 30, 2024: revenue $8.53M, net income −$11.2M, EPS −$1.98
• Quarter ended Mar 31, 2024: revenue $5.79M, net income −$9.08M, EPS −$1.66
• Quarter ended Dec 31, 2023 (from the annual report): revenue $7.16M, net income −$11.0M, EPS −$1.75
• Quarter ended Sep 30, 2023: revenue $0, net income −$14.4M, EPS −$3.29
• Quarter ended Jun 30, 2023: revenue $0, net income −$16.9M, EPS −$3.88
• Quarter ended Mar 31, 2023: revenue $0, net income −$19.0M, EPS −$4.46
• Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$22.4M, EPS −$21.61
• Quarter ended Sep 30, 2022: revenue n/a, net income −$23.1M, EPS −$0.48
• Quarter ended Jun 30, 2022: revenue n/a, net income −$24.5M, EPS −$0.51
• Quarter ended Mar 31, 2022: revenue n/a, net income −$23.1M, EPS −$0.48
• Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$60.3M, EPS −$1.35
• Quarter ended Sep 30, 2021: revenue $6.25M, net income −$18.8M, EPS −$0.41

ASMB cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$41.1M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$51.1M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $22.7M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$84.5M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$93.4M, share buybacks n/a

ASMB balance sheet

• Jun 30, 2026: cash $32.3M, total assets $331M, total liabilities $25.2M, shareholders' equity $306M
• Mar 31, 2026: cash $31.1M, total assets $236M, total liabilities $36.9M, shareholders' equity $199M
• Dec 31, 2025: cash $58.5M, total assets $258M, total liabilities $50.8M, shareholders' equity $207M
• Sep 30, 2025: cash $22.5M, total assets $240M, total liabilities $57.3M, shareholders' equity $183M
• Jun 30, 2025: cash $24.0M, total assets $80.8M, total liabilities $62.7M, shareholders' equity $18.1M
• Mar 31, 2025: cash $23.4M, total assets $99.0M, total liabilities $71.9M, shareholders' equity $27.1M
• Dec 31, 2024: cash $38.3M, total assets $119M, total liabilities $85.8M, shareholders' equity $33.4M
• Sep 30, 2024: cash $28.5M, total assets $100M, total liabilities $74.3M, shareholders' equity $26.0M

What is ASMB's revenue?

ASSEMBLY BIOSCIENCES INC reported $74.8M of revenue over its last four quarters, through June 30, 2026.

Is ASMB profitable?

No. ASSEMBLY BIOSCIENCES INC lost $42.0K over the last four quarters.

What is ASMB's EPS?

Diluted earnings per share over the last four quarters were $1.21; −$0.20 in the latest quarter.

ASMB ownership and insider trades · All stocks